Zdrowie i gospodarka · 24/03/2006

Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products; Correction

The Food and Drug Administration (FDA) is correcting a final rule that published in the Federal Register of May 25, 2004 (69 FR 29786). The final rule required human cell, tissue, and cellular and tissue-based product (HCT/P) establishments to screen and test cell and tissue donors for risk factors for, and clinical evidence of, relevant communicable disease agents and diseases. The document was published with an error in the codified section. This document corrects that error.